title: Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study.
abstract: Disease-modifying antirheumatic drug (DMARD) combination therapies are used widely, but there have been few reports clearly demonstrating that combination therapy is more effective than DMARD monotherapy. We conducted a multicenter, double-blind controlled trial in order to clarify that the combination of methotrexate and bucillamine is more effective than either alone. The subjects of this study were 71 patients with active rheumatoid arthritis within 2 years of onset. Dosages were 8 mg methotrexate with 5 mg folic acid per week (MTX group), 200 mg bucillamine per day (BUC group), or both MTX and BUC (combination group). Clinical effects and adverse reactions were observed for 96 weeks. The ACR 20 response rate was 79.2% in the combination group, significantly higher than the rates of 43.5% for the MTX group (P = 0.008) and 45.8% for the BUC group (P = 0.0178). The cumulative survival curve of maintaining the ACR 20 response was significantly higher in the combination group than in the MTX and BUC groups (P = 0.0123 and P = 0.0088, respectively). The mean increase in the total Sharp score over 96 weeks was 12.6 +/- 9.0 in the combination group, significantly lower (P = 0.0468) than the value of 28.0 +/- 28.3 for the single DMARD (combined MTX and BUC) group. The incidence of adverse reactions did not differ significantly between the three groups. It was concluded that the combination therapy with MTX and BUC showed significantly higher clinical efficacy than either of the single DMARD therapies.
authors.affiliation: Department of Rheumatic, Collagen and Allergic Diseases, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan. j-incho@aqua.ocn.ne.jp
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Ichikawa
authors.forename: Terunobu
authors.initials: T
authors.lastname: Saito
authors.forename: Hisashi
authors.initials: H
authors.lastname: Yamanaka
authors.forename: Masashi
authors.initials: M
authors.lastname: Akizuki
authors.forename: Hirobumi
authors.initials: H
authors.lastname: Kondo
authors.forename: Shigeto
authors.initials: S
authors.lastname: Kobayashi
authors.forename: Hisaji
authors.initials: H
authors.lastname: Oshima
authors.forename: Shinichi
authors.initials: S
authors.lastname: Kawai
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Hama
authors.forename: Hidehiro
authors.initials: H
authors.lastname: Yamada
authors.forename: Tsuneyo
authors.initials: T
authors.lastname: Mimori
authors.forename: Koichi
authors.initials: K
authors.lastname: Amano
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Tanaka
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Matsuoka
authors.forename: Sumiki
authors.initials: S
authors.lastname: Yamamoto
authors.forename: Tsukasa
authors.initials: T
authors.lastname: Matsubara
authors.forename: Norikazu
authors.initials: N
authors.lastname: Murata
authors.forename: Tomiaki
authors.initials: T
authors.lastname: Asai
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Suzuki